1-4 of 4
Michael P. Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors

Aslamuzzaman Kazi, Shengyan Xiang, Hua Yang, Liwei Chen, Perry Kennedy, Muhammad Ayaz, Steven Fletcher, Christopher Cummings, Harshani R. Lawrence, Francisca Beato, Ya'an Kang, Michael P. Kim, Andrea Delitto, Patrick W. Underwood, Jason B. Fleming, Jose G. Trevino, Andrew D. Hamilton, Said M. Sebti
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (19): 5984–5996.
https://doi.org/10.1158/1078-0432.CCR-18-3399
Published: 01 October 2019
View article titled, Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors
Open the PDF for Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors in another window
Includes: Supplementary data
Journal Articles

Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression

Vincent Bernard, Alexander Semaan, Jonathan Huang, F. Anthony San Lucas, Feven C. Mulu, Bret M. Stephens, Paola A. Guerrero, Yanqing Huang, Jun Zhao, Nabiollah Kamyabi, Subrata Sen, Paul A. Scheet, Cullen M. Taniguchi, Michael P. Kim, Ching-Wei Tzeng, Matthew H. Katz, Aatur D. Singhi, Anirban Maitra, Hector A. Alvarez
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (7): 2194–2205.
https://doi.org/10.1158/1078-0432.CCR-18-1955
Published: 01 April 2019
View article titled, Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression
Open the PDF for Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression in another window
Includes: Supplementary data
Journal Articles

A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma

Eugene J. Koay, Yeonju Lee, Vittorio Cristini, John S. Lowengrub, Ya'an Kang, F. Anthony San Lucas, Brian P. Hobbs, Rong Ye, Dalia Elganainy, Muayad Almahariq, Ahmed M. Amer, Deyali Chatterjee, Huaming Yan, Peter C. Park, Mayrim V. Rios Perez, Dali Li, Naveen Garg, Kim A. Reiss, Shun Yu, Anil Chauhan, Mohamed Zaid, Newsha Nikzad, Robert A. Wolff, Milind Javle, Gauri R. Varadhachary, Rachna T. Shroff, Prajnan Das, Jeffrey E. Lee, Mauro Ferrari, Anirban Maitra, Cullen M. Taniguchi, Michael P. Kim, Christopher H. Crane, Matthew H. Katz, Huamin Wang, Priya Bhosale, Eric P. Tamm, Jason B. Fleming
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (23): 5883–5894.
https://doi.org/10.1158/1078-0432.CCR-17-3668
Published: 03 December 2018
View article titled, A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma
Open the PDF for A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma in another window
Includes: Multimedia, Supplementary data
Journal Articles

Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players

Michael P. Kim, Gary E. Gallick
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1284–1285.
https://doi.org/10.1158/1078-0432.CCR-07-2247
Published: 03 March 2008
View article titled, Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players
Open the PDF for Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players in another window